Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Identification of a Potent Pan-Coronaviral Main Protease Inhibitor.
Journal: Journal of medicinal chemistry
Published: July 16, 2026
2-Substituted oxazolyl and thiazolyl amino acids are suitable P1 surrogates for new SARS-CoV-2 main protease inhibitors.
Journal: Organic & biomolecular chemistry
Published: June 16, 2026
Screening apelin analogues and a small molecule agonist as effective cardiovascular therapeutics against reperfusion injury.
Journal: RSC medicinal chemistry
Published: November 02, 2025
Structural insights into the nirmatrelvir-resistant SARS-CoV-2 Mpro L50F/E166A/L167F triple mutant-inhibitor-complex reveal strategies for next generation coronaviral inhibitor design.
Journal: RSC medicinal chemistry
Published: April 24, 2025
Peptide Aldehydes Incorporating Thiazol-4-yl Alanine Are Potent In Vitro Inhibitors of SARS-CoV-2 Main Protease.
Journal: ACS medicinal chemistry letters
Published: September 05, 2024
A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (Mpro) of SARS-CoV-2 and MERS-CoV.
Journal: JACS Au
Published: June 13, 2024
Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition.
Journal: Frontiers in chemistry
Published: January 11, 2022
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability.
Journal: Journal of medicinal chemistry
Published: July 09, 2021
Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators.
Journal: RSC medicinal chemistry
Published: April 06, 2021
Last Updated: 09/26/2026